Skip to main content

Health condition

Adrenoleukodystrophy adults

X-linked adrenoleukodystrophy in adults most often appears as adrenomyeloneuropathy - stiff legs, bladder trouble and adrenal failure - and recognising it protects both the patient and their wider family.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • Adult form (AMN): slowly progressive leg stiffness and weakness, balance problems, bladder urgency and erectile dysfunction from the 20s-40s

  • Adrenal insufficiency affects most affected men - fatigue, pigmentation, crises - and is treatable once found

  • A minority develop cerebral inflammation, which is monitored for by periodic MRI

  • Diagnosis: very long chain fatty acids in blood, confirmed by ABCD1 genetic testing

  • Female carriers commonly develop milder spinal cord symptoms in later life - they are not just carriers

  • Family cascade testing matters enormously: affected boys can be saved by early transplant, adults by adrenal treatment

Understanding it

About Adrenoleukodystrophy adults, and what to do next.

ALD's adult face is quieter than its childhood one but widely missed: a man in his 30s with stiffening, weakening legs, urinary urgency and fatigue, frequently mislabelled as hereditary spastic paraparesis or progressive MS for years. The unifying test is almost anticlimactic - plasma very long chain fatty acids, elevated in essentially all affected men - with ABCD1 sequencing confirming. Two immediate wins follow diagnosis. First, adrenal testing: most men with AMN develop Addisonian failure, an eminently treatable condition whose crises are dangerous only when unsuspected. Second, MRI surveillance, because a subset of adults develop the inflammatory cerebral form, and detecting it early gates access to intervention.

The family dimension is the largest lever in the disease. Each diagnosis illuminates a pedigree: sisters and mothers who may carry the gene (and often themselves develop spastic gait in mid-life, deserving symptom care rather than dismissal), nephews and sons for whom early identification is life-changing - boys found presymptomatically can be monitored and transplanted at the narrow window when cerebral disease starts, and newborn screening exists in some countries for exactly this reason. Genetic counselling therefore is not an appendix to the diagnosis but half its value. Care sits with neurology, endocrinology and clinical genetics jointly; specialist leukodystrophy or metabolic clinics coordinate best.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.

Frequently asked

Common questions about Adrenoleukodystrophy adults.

Quick, plain-English answers to what people ask us most.

  • What is adrenoleukodystrophy in adults?

    Adrenoleukodystrophy (ALD) is a rare inherited metabolic disorder causing a build-up of certain fatty acids in the body, affecting the adrenal glands and nervous system, with the adult-onset form typically causing progressive neurological symptoms.

  • What causes adrenoleukodystrophy?

    It is caused by mutations in the ABCD1 gene, which impairs the breakdown of very long chain fatty acids, allowing them to accumulate and damage the adrenal glands and nervous system over time.

  • What are the symptoms of adult adrenoleukodystrophy?

    Symptoms often include progressive difficulty walking due to spinal cord involvement, bladder problems, and sometimes symptoms of adrenal insufficiency such as fatigue and low blood pressure, developing gradually in adulthood.

  • Is adrenoleukodystrophy dangerous?

    Yes, it can cause significant, progressive neurological disability, and associated adrenal insufficiency can be life-threatening if unrecognised, making early diagnosis and appropriate management important.

  • Is adrenoleukodystrophy genetic?

    Yes, it is an X-linked genetic condition, meaning it is caused by a mutation on the X chromosome and predominantly, though not exclusively, affects men, with female carriers sometimes developing milder symptoms later in life.

  • Can adrenoleukodystrophy be cured?

    There is no cure for the neurological aspects in established adult-onset disease, but adrenal insufficiency can be effectively treated with hormone replacement, and some specialist centres offer additional supportive and disease-monitoring treatments.

  • How is adrenoleukodystrophy managed?

    Management includes regular monitoring for adrenal insufficiency with hormone replacement if needed, physiotherapy and mobility support for neurological symptoms, and genetic counselling for affected families.

  • How does adult-onset ALD differ in progression?

    Adult-onset ALD (sometimes called adrenomyeloneuropathy) tends to progress more slowly than the severe childhood cerebral form, primarily affecting the spinal cord and peripheral nerves rather than causing rapid brain deterioration.

  • Adult adrenoleukodystrophy vs childhood cerebral ALD — what's the difference?

    Childhood cerebral ALD causes rapid, severe brain deterioration typically in boys, often within a few years of onset, while adult-onset ALD progresses more gradually, mainly affecting the spinal cord and peripheral nerves over many years.

  • When should I see a doctor about possible adrenoleukodystrophy, and how quickly can I be seen privately?

    See a doctor if you have a relevant family history or unexplained progressive walking difficulty with possible adrenal symptoms. NHS specialist referral can take many weeks, while private neurology or endocrinology assessment is often available within about two weeks.